Focus research 2022 DynAct team
Advances in cytotoxic T lymphocyte function IOver the past year, the DynAct team’s research has progressed along three main lines:
- In collaboration with the ATTACK consortium funded by the prestigious European ERC Synergy Grant, the team has helped characterize the lytic compartment of cytotoxic T lymphocytes (CTL). Read article
- The team has shed new light on the molecular mechanisms by which aggressive tumors such as melanoma resist CTL attack at the lytic synapse. Read the article
- In collaboration with Dr. Sylvain Cussat-Blanc (Institut de Recherche en Informatique de Toulouse – IRIT), the team has developed a new approach to instance segmentation in microscopy that takes advantage of the highly innovative application called Cartesian Genetic Programming (CGP) of biological images. A patent application has been filed for this program and an article has been submitted for publication (K. Cortacero et al, under revision).
To find out more about the IUCT-Oncopole and CRCT-Oncopole research focuses, please click here
Toulouse Cancer Research Center (Oncopole)
Toulouse - FR
CRCT-Oncopole Follow 1,433 1,279
Compte officiel du Centre de Recherches en Cancérologie de Toulouse
;
🇬🇧Cytidine deaminase-dependent mitochondrial biogenesis as a potential vulnerability in pancreatic cancer cells. ImPact team @CordelierPierre article from @crctoncopole published in @CommsBio
➡️https://www.crct-inserm.fr/en/targeting-the-energy-production-process-in-pancreatic-cancer-cells-which-relies-on-an-enzyme-called-cytidine-deaminase-could-make-these-cells-more-vulnerable/
Contact us
+33 5 82 74 15 75
Want to join
the CRCT team ?
